O-022Outcomes based on Albumin‐Bilirubin (ALBI) grade in the phase 3 CELESTIAL trial of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma (HCC)
Miksad, R, Cicin, I, Chen, Y, Klumpen, H, Kim, S, Lin, Z, Youkstetter, J, Sen, S, Cheng, A, Meyer, T, Kelley, R, Abou-Alfa, GVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz154.021
Date:
July, 2019
Fichier:
PDF, 79 KB
2019
File converter
Plus de résultats de recherche
More benefits 
